Polar Capital Holdings’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.2M Sell
2025
Q1
$13.3M Buy
2024
Q4
$17.5M Buy
2024
Q3
$14.7M Hold
2024
Q2
$11.8M Hold
2024
Q1
$19M Hold
2023
Q4
$10.8M Buy
2023
Q3
$3.67M Buy